Evidence map›Paper›PMID 36567960›Full record

ArticleNature machine intelligence2022

Deep learning models for predicting RNA degradation via dual crowdsourcing.

Hannah K Wayment-Steele, Wipapat Kladwang, Andrew M Watkins, Do Soon Kim, Bojan Tunguz, Walter Reade, Maggie Demkin, Jonathan Romano, Roger Wellington-Oguri, John J Nicol and 19 more

Abstract read
In one paragraph

Article in Nature machine intelligence, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. Review
  2. Review
  3. Gradient-based optimization for mRNA sequence design.Bioinformatics (Oxford, England) · 2026
    Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Advances in Protein Function Prediction from the Fifth CAFA Challenge.bioRxiv : the preprint server for biology · 2026
    Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

29 authors.

Hannah K Wayment-Steele *Department of Chemistry, Stanford University, Stanford, CA USA.ORCID 0000-0003-4949-2010
Wipapat Kladwang *Eterna Massive Open Laboratory, Stanford, CA USA.
Andrew M Watkins *Eterna Massive Open Laboratory, Stanford, CA USA.
Do Soon Kim *Eterna Massive Open Laboratory, Stanford, CA USA.
Bojan Tunguz *Department of Biochemistry, Stanford University, Stanford, CA USA.
Walter ReadeKaggle, San Francisco, CA USA.ORCID 0000-0002-9215-700X
Maggie DemkinKaggle, San Francisco, CA USA.
Jonathan RomanoEterna Massive Open Laboratory, Stanford, CA USA.ORCID 0000-0003-4031-0102
Roger Wellington-OguriEterna Massive Open Laboratory, Stanford, CA USA.
John J NicolEterna Massive Open Laboratory, Stanford, CA USA.
Jiayang GaoHigh-flyer AI, Hangzhou, Zhejiang China.ORCID 0000-0003-0650-2581
Kazuki OnoderaNVIDIA Corporation, Minato-ku, Tokyo, Japan.
Kazuki FujikawaDeNA, Shibuya-ku, Tokyo, Japan.ORCID 0000-0002-0372-689X
Hanfei MaoYanfu Investments, Shanghai, China.ORCID 0000-0001-6319-3581
Gilles VandewieleIDLab, Ghent University, Technologiepark-Zwijnaarde, Gent, Belgium.ORCID 0000-0001-9531-0623
Michele TintiThe Wellcome Centre for Anti-Infectives Research, College of Life Sciences, University of Dundee, Dundee, UK.ORCID 0000-0002-0051-017X
Bram SteenwinckelIDLab, Ghent University, Technologiepark-Zwijnaarde, Gent, Belgium.
Takuya ItoUniversal Knowledge Inc., Tokyo, Japan.
Taiga NoumiKeyence Corporation, 1-3-14, Higashi-Nakajima, Higashi-Yodogawa-ku, Osaka, Japan.
Shujun HeDepartment of Chemical Engineering, Texas A&M University, College Station, TX USA.
Keiichiro IshiRist Inc., Shimogyo-ku, Kyoto, Japan.
Youhan LeeKorea Atomic Energy Research Institute, Daejeon, Republic of Korea.
Fatih ÖztürkH2O, Istanbul, Turkey.
King Yuen ChiuClover Health, Hong Kong, P. R. China.ORCID 0000-0001-6438-8479
Emin ÖztürkAfiniti, Istanbul, Turkey.
Karim AmerCenter for Informatics Science, Nile University, Sheikh Zayed, Giza, Egypt.
Mohamed FaresCenter for Informatics Science, Nile University, Sheikh Zayed, Giza, Egypt.ORCID 0000-0003-3600-3716
Eterna Participants
Rhiju DasEterna Massive Open Laboratory, Stanford, CA USA.ORCID 0000-0001-7497-0972

Funding

Next-generation computational/chemical methods for complex RNA structuresR35GM122579 · NIGMS · STANFORD UNIVERSITY · PI Rhiju Das · 2017 to 2026
$7.2M
NIGMS NIH HHS R35 GM122579
6 · The paper itself

Abstract

Medicines based on messenger RNA (mRNA) hold immense potential, as evidenced by their rapid deployment as COVID-19 vaccines. However, worldwide distribution of mRNA molecules has been limited by their thermostability, which is fundamentally limited by the intrinsic instability of RNA molecules to a chemical degradation reaction called in-line hydrolysis. Predicting the degradation of an RNA molecule is a key task in designing more stable RNA-based therapeutics. Here, we describe a crowdsourced machine learning competition ('Stanford OpenVaccine') on Kaggle, involving single-nucleotide resolution measurements on 6,043 diverse 102-130-nucleotide RNA constructs that were themselves solicited through crowdsourcing on the RNA design platform Eterna. The entire experiment was completed in less than 6 months, and 41% of nucleotide-level predictions from the winning model were within experimental error of the ground truth measurement. Furthermore, these models generalized to blindly predicting orthogonal degradation data on much longer mRNA molecules (504-1,588 nucleotides) with improved accuracy compared with previously published models. These results indicate that such models can represent in-line hydrolysis with excellent accuracy, supporting their use for designing stabilized messenger RNAs. The integration of two crowdsourcing platforms, one for dataset creation and another for machine learning, may be fruitful for other urgent problems that demand scientific discovery on rapid timescales.

Indexed as

Machine learningRNA

Identifiers

PMID36567960
PMCPMC9771809

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.